Let's talk medical research

Alzheimer’s disease, the most prevalent type of dementia, is diagnosed in more than 6 million Americans. Estimates project that by 2050, 13 million individuals will be diagnosed with Alzheimer’s disease. This condition ranks among the top 10 causes of death in the United States, profoundly impacting those diagnosed, their loved ones, and their caregivers. Currently, Alzheimer’s remains a disease ...

Today, Antidote is excited to announce our collaboration with Beyond Type 1 and JDRF to release the first-ever Spanish-language clinical trial search engine for type 1 diabetes (T1D). This groundbreaking version of Antidote Match™ empowers users to search for type 1 diabetes trials in their preferred language, marking a significant step to improve diversity, equity, and inclusion in diabetes ...

Primary sclerosing cholangitis (PSC) is a condition that impacts the bile ducts of the liver, causing them to become inflamed and ultimately scar. It primarily affects young and middle-aged men, and 80% of patients with PSC also have inflammatory bowel disease (IBD).

Helping patients find out about clinical trials is one of the chief pillars of the work Antidote does, and one of the ways we do this is through our partners. By building a network of nonprofits and patient advocacy groups, we are able to reach patients where they are and help them find clinical trial opportunities that may be a good fit.

Persistent corneal epithelial defects are more than just an eye injury. The corneal epithelium is an integral part of the eye, tasked with guarding against infection and structural damage. While most injuries to the corneal epithelium are able to heal within a week, these persistent injuries will continue well past the seven-day mark. If they remain unresponsive to standard treatments, the ...

Before any new therapy can be put on the market, it must be tested to ensure its safety and effectiveness, and the research for this process is done through clinical trials. Clinical trials evaluate new drugs, devices, packaging, and behaviors in order to determine if these potential therapies work for particular conditions or patient populations.

IgA nephropathy, also known as IgAN or Berger disease, is a common kidney disease that can impact any individual at any age. It is one of the most prevalent kidney diseases other than those caused by diabetes or high blood pressure, but the cause and the cure for this condition remain unknown.

For medical research to advance, the participation of individuals in a clinical trial is essential. However, accessing trial sites can present an undue burden. A survey about barriers to clinical trial participation found that the primary reason patients declined to enroll in a study was due to the inconvenience associated with travel. This is backed up by research from Deloitte, which reveals ...

Breast cancer as defined by the Centers for Disease Control and Prevention (CDC) is “a disease in which cells in the breast grow out of control.” It is the second leading cause of cancer-related death in women, and approximately 264,000 new cases are diagnosed in the United States each year.

Celiac disease is a common autoimmune disorder that causes a reaction to gluten within the small intestine. It is often underdiagnosed, but it is estimated to impact around 2 million people in the United States.